Connect with us


Medical Cannabis – Can It Help Treat Asthma?



medical cannabis

The legalization of the cannabis industry and the increased popularity of medical cannabis has raised some questions. Consumers are curious about the healing power of medicinal cannabis, and whether or not, it can treat asthma. Asthma is a lung disease that affects individuals and causes the narrowing or inflammation of the airways. Common symptoms may include difficulty breathing, coughing, and wheezing.

Asthma, sadly, has no cure. However, many treatment options are available to manage the symptoms and prevent further complications. Moreover, researchers are intrigued by the connection between medicinal cannabis and asthma. The question though is the consumption method. Most people smoke cannabis, which isn’t a very healthy option for asthma patients.

Medical cannabis

Studies show that specific components of cannabis can be potentially beneficial for asthma patients. Medicinal cannabis can be a reference to the entire plant or a specific beneficial component which later forms the medication. However, to understand the difference between medicinal cannabis and recreational cannabis is essential.

Medical cannabis uses specific cannabinoids to interact with the endocannabinoid system of the body, to target specific responses. Medical cannabis is widely used to treat and/or alleviate the symptoms of a lot of different issues, which can include, depression, anxiety, menopause, endometriosis, PTSD, cancer, inflammation, arthritis, etc.

A lot of people smoke cannabis for recreational purposes. However, this can negatively affect the lungs, which can be a further complication for asthma patients. Smoking of any kind can cause irritation to the lungs, of a healthy individual as well, which can lead to further complications.

The use of medicinal cannabis in other forms can add more benefits and safety for asthma patients. Multiple options can also include consumption of cannabis or extracts in tea or food (commonly known as edibles), consumption of the active and primary ingredients in the form of capsules, and the application of topical preparations right onto the skin.


Cannabis generally contains various active compounds commonly known as cannabinoids. These compounds also include the most popular cannabinoids, CBD (cannabidiol) and THC (tetrahydrocannabinol). THC is primarily a psychoactive compound. Unlike CBD, it gives the feeling of high or a sense of euphoria. CBD does not produce any mind-altering effects.

CBD and THC are one of the many compounds in cannabis that can provide several health benefits. The anti-spasmodic and anti-inflammatory properties are examples. Some individuals use cannabis in an attempt to treat chronic illnesses that cause inflammation and pain, like multiple sclerosis (MS). While many countries have legally approved the use of medicinal cannabis for these purposes, the United States did not participate.

Researchers have studied the safety of cannabis for patients suffering from asthma and other inflammatory conditions. An animal study from 2015, showed that CBD could be potentially beneficial for asthmatic patients due to its anti-inflammatory properties. The FDA (U.S Food and Drug Administration), however, has not legally declared the use of medicinal cannabis for asthma.


Currently, there is a lack of substantial evidence to construct a conclusive outcome that would ensure the safety and effectiveness of medical cannabis for asthma. Although, there is a possibility that the anti-spasmodic and anti-inflammatory properties of medical cannabis could alleviate the symptoms of asthma. In June 2018, the use of a pure form of CBD was approved by the FDA.

The FDA also approved Epidolex, which was a drug used for the treatment of 2 severe but rare forms of epilepsy. these forms of epilepsy usually do not interact with any other medication. Research shows the ability of THC to suppress the body’s immune system. This further helps in t reduction of the symptoms projected from autoimmune diseases, one of which is asthma. As asthma is typically an allergic reaction the over-reaction of the immune system is caused due to a triggering environment.

Studies show that a form of THC may potentially have bronchodilator properties, hence, help to make breathing easier for asthmatic patients. However, commonly it can prove to be difficult to study the impact of cannabis and its compounds. This is due to the reason that most people using cannabis, tend to use the entire plant by regularly smoking. This makes the assessment of the compounds and their positive effects, harder.


Although beneficial, there might be some risks involved. Studies have shown that smoking cannabis can potentially trigger an asthma attack, as any other form of smoking. It may also develop further risks of allergies. Smoking cannabis while suffering from an asthma attack could cause irritation in the lungs, heighten health risks, and worsen coughing.

However, for medical cannabis in non-smoking alternatives, there may be side effects including

  • fluctuations in mood and perception
  • lessened coordination
  • difficulty in remembering, reasoning, and thinking

A doctor’s supervision and advice are essential when using medical cannabis, to minimize the risks.

Legal issues

The laws surrounding cannabis, for both medical and recreational purposes, are constantly evolving with new changes. While some states and countries have legalized cannabis for both purposes, many have only legalized medical cannabis, while others haven’t legalized either. Hence it is important to check your state and federal laws before trying to obtain and/or use cannabis.

Many forms of medical cannabis, like CBD oil, are legal. However, there are restrictions involved and a need for prescriptions. CBD oil and many cannabis products that do not require FDA approval, are not regulated either. This can cause further ambiguity regarding the contents of the cannabis product. Furthermore, cannabis is not approved by the FDA, for treating asthma.

Like any other medication, a consultation with a licensed doctor is necessary. Any additional treatments for any chronic illnesses, like asthma, should be consulted with a doctor, to understand drug-to-drug interactions, along with the risks and side effects involved.

Since medical cannabis can have potential risks associated as well, a licensed doctor is the best individual to refer to, for a better understanding regarding the effectiveness of the treatment.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *


Recycling Of Tonnes Of Cannabis Containers



Cannabis Recycling

Cannabis products formulations in solid, liquid, and smoke-able forms are available in the market for medical and recreational use. Marijuana products are kept under storage conditions set out by the manufacturer. 


Cannabis products come in containers of variable sizes and shapes. The material used to prepare containers depends upon the manufacturer’s choice and demand for the stability of marijuana products. 

ALSO READ: Cannabis Products Association With Perceived Risks And Availability


Recycling of containers is occurring for decades to reuse items or process used items into new ones. Doing so reduces pollution and helps to use one material multiple times. 


Returning And Recycling Of Cannabis Containers To SDQC


In less than 12 months, about 21 tonnes of empty plastic containers were sent to recycle to the SQDC. SQDC is the company that does the recycling under the name Societe Quebecoise du cannabis. It is a government-owned company. 


The company began its recycling package or recovery program in August 2020. Since August, a lot of plastic containers have gone through recovery programs, precisely 2291143 containers.


The use of cannabis products has hugely increased in the market. The number of marijuana containers purchased by consumers is likely to be much more than the number of containers send to SQDC to recycle. There is only a deposit on SQDC beverages included in the RECYCQUEBEC consignment system. 


However, there is no deposit on the SQDC containers in the system. Quebecers who do return pot containers do so not for money as they do not get money. They do so to keep containers away from trash.


According to the SDQC, the benefit of returning empty containers is that others materials cannot contaminate cannabis containers. Moreover, doing so ensures that these packaging materials do not end up in the blue boxes. Collecting these empty plastic packaging allows sending a uniform material to businesses that reuse it easily after quick processing.


What Happens To Marijuana Containers After Recycling


The Societe Quebecoise du cannabis signed a partnership with TerraCycle. TerraCycle is a U.S.-based recycling business company. The SQDC sends collected cannabis containers to TerraCycle and other such companies that are in agreement to recycle them. 


TerraCycle recycling business company focuses on using the used items to form urban furniture such as park benches, flower boxes, etc. According to some individuals, TerraCycle recycles bags that could have added to pollution or result in a landfill otherwise.


According to the Canadian press, it is uncertain what happens to those containers. It is also unclear how many of such packagings go into and out of the company. No one knows the exact number of plastic packaging required to produce urban furniture. Furthermore, there is little knowledge about other formulations that use this recyclable material. So far, there is no way to find it as the TerraCycle recycling business company does not respond to emails or phone calls as per the Canadian press. 

ALSO READ: Changes In Cannabis Proposed Ordinance By Santa Fe County Planning Commission


The SQDC, in a Facebook post on a page, announces that they will continue to work to improve the environment. They are working with a team of experts to develop an efficient action plan for cannabis containers and packaging recycling that is eco-friendlier. They are looking forward to going further with their environmental efforts. 

Environmentally Unsustainable?

Some people are criticizing SDQC for its products that are considered over-packaged or are environmentally unsustainable. Individuals complain that they have to wait in line to return the cannabis containers, and it would be much better if SQDC places outdoor bins in front of SQDC branches. Some individuals, while returning multiple marijuana containers, feel embarrassed. 


SQDC replied to these complaints and said that they are aware of the critical remarks. However, they cannot do much about it as they are to abide by the law. Placing outdoor bins cannot ensure control over the material. Outdoor recycling bins can increase the risk of accidental cannabis consumption in children and youth.  

Continue Reading


Pot Legal In NYC But Where To Buy Recreational Cannabis In New York



Cannabis Companies Making Moves Before New York Begins Recreational Cannabis Sales

Pot products, including recreational cannabis and medical marijuana products, are legal in New York. The lawmakers have successfully approved the weed legalization and decriminalization bill. However, the administration working and policies to implement the bill is taking way too much time. 


The disagreements among legislators and the inability to develop a plan to implement the legislation delays implementation of the new bill. Due to delays in proceeding procedures, things have become difficult for almost everyone. 


Cannabis Legalization Program Of New York – A Train To Nowhere


Governor Andrew Cuomo and state legislatures did approve cannabis legalization and decriminalization bill in March this year. However, there has not been much progress. According to critics, the Governor is the real buzzkill on the issue. 

ALSO READ: Cannabis Products Association With Perceived Risks And Availability

Critics elaborate that Cuomo is yet to nominate an executive director for his new Office of Cannabis Management. He also has to name appointees to the Cannabis Control Board. The Marijuana Taxation and Regulation Act were passed months ago, yet the official is working slowly to appoint and name some people for the office to begin further proceedings. 


The Governor is delaying the procedure because the Senate members have not yet passed Cuomo’s proposed MTA legislation. Richard Azzopardi is the spokesperson of Gov. Andrew Cuomo. According to his spokesperson, there are multiple unfinished businesses in Senate. However, they will submit their nominees and names for designated positions. The spokesperson also mentioned that they hope Senate passes MTA legislation and let nominees selected by the governor implement order regarding cannabis. 


Politicians Against Delay In Implementation Of Cannabis Legalization Policy In New York 


Mike Murphy is the spokesman for Senate Leader Andrea Stewart Cousins. According to Murphy, MTA approval and nominating nominees are separate issues with no interlinkage. Thus, these matters need separate resolutions, and it is best not to try to relate them. 


According to State Senator Diane Savino, after observing the current situation, it is evident that the cannabis legalistic program is likely to delay for much a longer time. She added that the public and officials of New York are in between a rock and a solid hard place. 


Moreover, apart from the politicians, the public is angry and frustrated at the delay of matters. Residents of the state are unable to understand the logic or reasoning behind the pending situation. 


According to Diane Savino, legislatures or lawmakers should walk and sign a joint agreement at the time regarding the subject to settle things as quickly as possible.


The politician further added that nothing can happen concerning marijuana sale policy and license issuance to begin a legal business. At least until regulators develop a set of ground rules to conduct cannabis business, following legal practices is impossible. 


What Is More About Marijuana Policy In New York State?


According to Diane Savino, no operation involving marijuana is practicable unless legislators set some ground rules. Licenses to individuals to begin a legal sale, cultivation, processing, manufacturing, or distribution of marijuana is unapprovable before settling some limitations. Moreover, it is inappropriate to approve licenses without designing a regulatory system. 

ALSO READ: Cannabis Dealer Stopped By Police

Governor needs to select three people to begin the formation of the five-member Cannabis Control Board. The nominees will first get approval from the Senate to offer their services. The selection of the other two members falls on the legislatures. One member of the five-member committee will be selected by lawmakers from the Assembly and one from the Senate. 


The selection of nominees and their approval is the next step after passing the bill, and it took almost a year for completion. Delaying the process cause trouble for the state and the public who had to go to borders to purchase cannabis legally from neighboring states like Massachusetts. 


Unless the regulatory and administrative procedures are incomplete, the state is unable to generate revenue. Pending them will only slow down the development process of the cannabis business field and delay experiencing possible benefits from its tax revenue. 

Originally covered on: NYPost

Continue Reading


Cannabis Products Association With Perceived Risks And Availability



Medical cannabis

Cannabis products are in use for medical and recreational purposes in more than thirty states of the United States. Some of these states allow medical marijuana products, while others allow pot for all purposes, including adult and medical purposes. 


Multiple studies have been conducted relating to cannabis, including pot effects and associations with other factors. Perceived risks and availability links with marijuana use disorders. Moreover, research findings can demonstrate how perceived risks can alter pot use disorders in individuals. 


According to a new study at Columbia University Mailman School of Public Health, perceptions of the risks and availability of cannabis influence the risk of pot use. This influence is more than the perceived risk and effect of perceived availability alone. 

ALSO READ: Marijuana Growing In Zimbabwe Is The New Farming Trend


The research discovers that individuals that perceive cannabis as a low-risk and available drug are more likely to use cannabis. There are some other findings too. Researchers discovered that individuals with perceptions that cannabis is high-risk and unavailable drug report fewer drug use cases. You can find research discoveries in the journal Drug and Alcohol Dependence. 


More About Research Regarding Perceived Risks And Availability Effects On Cannabis Use


Natalie Levy is a Doctoral Student of the Department of Epidemiology at Columbia Mailman School and the first author of the study. According to this research, perception of cannabis risk affects its use, frequency of use, and pot use disorders. Moreover, the availability of cannabis does influence the chances of drug use, its frequency, and marijuana use disorders. 


However, the findings show that cannabis risks and availability together influence pot use more frequently. The research focused on the evolution of collective perceptions of marijuana risk and availability from 2002 to 2018. 


Data of 949,285 participants helped in doing the investigation or survey studies. These participants are from the National Surveys on Drug Use and Health. Researchers found that over the years from 2002 to 2018, more people perceive marijuana as a low-risk drug. The prevalence of individuals who perceive pot as a low-risk drug doubled in these years. However, the influence of the change in availability perception was comparatively less evident. 


The joined perceptions influence was evident in these years. The percentage of individuals with the perception of cannabis as low-risk and available increased from 17% to 36% from 2002 to 2018, respectively. The number of individuals who perceive marijuana as a high-risk and available or unavailable drug decreases in these years. The percentage of people who perceive pot as high-risk and available is 26 percent. Meanwhile, the percentage of individuals that consider weed as high-risk and unavailable is twenty-seven percent. 


Marijuana Perception Effects


According to findings, individuals who regard cannabis as low-risk have reported and are likely to report six times more about pot use. Individuals with the perception of cannabis being available are five times more likely to use pot.

ALSO READ: Cannabis Legislation Back From The Dead For Better In Arizona

However, joined perceptions increase the chances of pot use. Individuals with joined perceptions are twenty-two times more likely to use marijuana. That is, people who perceive cannabis as a low-risk and available drug are more than 22 times more likely to use pot than people with the opposite perception.


Marijuana perceptions vary from males to females. A large percentage of the male population views marijuana as a low-risk, more available drug when compared to females. Researchers noted variations in pot perceptions in different age groups of each gender. According to the study, individuals of age 12-17 years show minimal cannabis perception differences. 


Silvia Martins, MD, Ph.D., is an associate professor of epidemiology at the Columbia Mailman School. She is the director of the Substance Use Epidemiology Unit of the Department of Epidemiology. She is also the senior author of the study. According to Martins, their research will open a new pathway for searching specific hypotheses. Moreover, the study highlights the importance of exploring joint perceived risks and availability on cannabis use. 

Originally covered on: news-medical

Continue Reading


error: Content is protected !!